Overview

Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)

Status:
Suspended

Trial end date:
2021-10-25

Target enrollment:

Participant gender:

Summary

This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Baptist Health South Florida

Collaborator:

University of California, Los Angeles

Treatments:

Colchicine